Eli Lilly

Page 7 of 7

J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
U.S. Multinationals in Puerto Rico
Finance

Eli Lilly’s Outlook for 2016 Disappoints

By
January 5, 2016
CHINA-ECONOMY-STOCKS
Retail

China Stocks and December Auto Sales–5 Things to Know Today

By
January 5, 2016
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
Health

Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight

By
December 1, 2015
U.S. Multinationals in Puerto Rico
Health

FDA Approves New Eli Lilly Drug for Advanced Lung Cancer

By
November 24, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance

Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last

By
October 12, 2015
General Views of Eli Lilly & Co.
Health

Why drug maker Eli Lilly’s stock price is down big today

By
October 12, 2015
Apple Worldwide Developers Conference Opens In San Francisco
Features

Apple, Greek banks, and earnings — 5 things to know this week

By
July 19, 2015

Most Popular